Kelly King, BB&T chairman and CEO, reacts to the role mortgage lending played in its weak quarterly report. King says the current yield curve reflects a slow economy.» Read More
Jack Welch, former GE chairman & CEO, shares his thoughts on the continued financial crisis in Europe; and the outlook on the U.S. economic recovery.
"We are investing a lot of money," says Peter Evensen, Teekay Corporation CEO, discussing how his company is profiting in the shipping space, despite facing strong economic headwinds, and benefiting from the increase in liquid natural gas production.
Ron Cohen, Acorda Therapeutics president & CEO, offers insight on just how much potential his company's multiple sclerosis drug "AMPYRA" has in the pharmaceutical market.
Jean-Jacques Bienaime, BioMarin Pharmaceutical CEO, discusses his company's efforts to develop treatment products for Lysosomal Storage Disorders. "We are the opposite of big pharma, we look at a significant improvement in a small patient population," says Bienaime.
Christopher Viehbacher, Sanofi CEO, discusses his company's acquisition of Genzyme and where he sees further deals in the pharmaceutical industry.
Insight on the Fed's meeting, with Thomas Belesis, John Thomas Financial CEO, and CNBC's Rick Santelli, Steve Liesman & Brian Shactman.
The "Street Signs" crew and Jan Kniffen, J. Rogers Kniffen WWE CEO, discuss the recent decline in JC Penney, whether its advertising strategies reach its customers, and the departure of the company's president Michael Francis.
Richard Pops, Alkermes CEO, says it's a good time to be developing new medicines if you have access to capital. "Biotech industry is the lifeblood-- the wells spring-- of new innovation for the big pharmaceutical companies," he says.
John Coustas, Danaos president & CEO, discusses the slowdown in the shipping industry and what it indicates about the health of the global economy.
Nelson Peltz, Trian Partners chairman & CEO, discusses his fund's 5.1% stake in the investment bank.
"We are going to be the largest buyer of prescription drugs," says Gregory Wasson, Walgreen CEO, with Stefano Pessina, Alliance Boots executive chairman, discussing Walgreen's $6.7 billion deal to buy a 45 percent stake in Alliance Boots with an option to buy the rest of the company.
Checking on the state of the U.S. economy amid the ongoing crisis in Europe and ahead of the Fed meeting, with Ron Kruszewski, Stifel Nicolaus CEO and Jack Bouroudjian, Bull and Bear Partners CEO.
Shares of MarkWest Energy Partners are down 17% since the beginning of May, and the company's chairman & CEO Frank Semple, discusses master limited partnerships and the company's growing income from fee-based contracts.
CNBC's Jon Fortt reports on the details of Microsoft's mystery tablet announcement; and Hans Humes, Greylock Capital president and CEO, offers insight on how to invest in European sovereign debt.
Citigroup CEO Vikram Pandit discusses the bank's long, restructuring project, with CNBC's Maria Bartiromo. "Where we are today, we think we're sized well for this environment," he says.
Vikram Pandit, Citigroup CEO, discusses the bank's restructuring, Europe and more.
Vikram Pandit, Citigroup CEO, discusses the outlook on the banking giant as it enters its third century and where he sees rebound in the housing market.
CNBC's Michelle Caruso-Cabrera reports the latest fallout from Sunday's pro-bailout election win in Greece, and Lawrence Lindsey, The Lindsey Group, president & CEO, discusses the impact of the Greek election on stocks and bond yields.
Harold McGraw, McGraw-Hill chairman, president & CEO, discusses ways of creating economic opportunities and enhancing global capital markets, from the business leaders meeting in Cabo, Mexico.
Samuel Allen, Deere & Company chairman & CEO, offers insight on global demand for its equipment, the European debt crisis and China.